Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Noveko International Inc T.EKO

TSX:EKO - Post Discussion

View:
Post by Cyberpatriote on Apr 05, 2012 4:42pm

Déception

Je suis déçu de voir que malgré les bonnes nouvelles, le titre stagne ou régresse. J'imagine que plusieurs d'entre vous partagent ce sentiment.

À mon humble opinion, c'est la présence de Third Eye Capital qui nuit à la confiance des investisseurs. Si EKO vendait sa filiale ECM à bon prix, elle pourrait rembourser ses dettes et peut-être avoir des $ en réserve.

Qu'en pensez-vous ?

Comment by domdesm on Apr 05, 2012 6:02pm
This post has been removed in accordance with Community Policy
Comment by bambam98ca on Apr 05, 2012 6:59pm
91 mill shares at .24 gives a total of 21 mill$ If ECM is worth 30 mill then they better keep it! Or the share price could drop to negative numbers lolololol
Comment by MoneyK on Apr 07, 2012 11:31am
ECM generated 10 million in sales last year.   I didn't analyse many medical companies, but CryoCath got sold for about 400M. It had about 40M outstanding shares and generated 40M in sales. Do the math, ECM could be worth 30M.   MoneyK      
Comment by MoneyK on Apr 07, 2012 11:47am
Other comparaisons. https://www.mddionline.com/article/mas-key-device-growth-strategies MoneyK
Comment by venture4500 on Apr 07, 2012 11:52am
Comparer Cryocath avec une compagnie qui fait des echograph rectal ...... way off the track buddy..... s'ils vendent ECM it's the end....ils ont rien d'autre ...... c,est pas avec des contrats de ma rde comme STM que la compagnie va survivre.....anyway
Comment by bambam98ca on Apr 07, 2012 2:56pm
If they could really get 30 mill for ECM and don't sell then they are dumber than we may imagine! It would clear their debts and get third eye of their azzes If they don't sell and they have a buyer then they are jeopordizing stockholder's investements and are sueable!
Comment by MoneyK on Apr 07, 2012 4:22pm
Je crois que ECM a le potentiel pour sortir 3 millions de profits par année et se vendre 30M.   Combien vous pensez que ça vaut et pourquoi?     Vous êtes très bon pour toujours critiquer, mais vous n'apportez rien de constructif et aucun échange d'idées...   MoneyK
Comment by bambam98ca on Apr 07, 2012 5:31pm
tu viens d'y repondre toi meme a 3 millions ca prendrait 10ans alors ca vaut 10 mill et soit y vendent ou y perdent tout
Comment by MoneyK on Apr 08, 2012 10:26am
C'est assez commum de payer 10 fois les bénéfices ou 3x les ventes lors d'un achat.   Ce qu'il faut comprendre ici, c'est que les ventes sont de +10M.  Pour une compagnie qui possède déja les ressources nécessaires, ca peut être très profitable d'acheter ECM et faire une extension de leurs gammes de produits.  Les coûts d ...more  
Comment by bambam98ca on Apr 08, 2012 9:24pm
Es tu entrain de dire que le Management de Noveko sont trop pauvre et incompetents pour faire la meme chose q'un acheteur?
Comment by MoneyK on Apr 09, 2012 11:26am
Bambam, je suis sur que tu es capable de comprendre que ça prends pas mal la même structure organisationelle pour vendre 1 produit ou pour en vendre 10.   Ça n'a aucun rapport avec le management.  En tout cas...   MoneyK    
Comment by bambam98ca on Apr 09, 2012 12:47pm
FAUX
Comment by bfw on Apr 09, 2012 1:05pm
Absolutely correct MoneyK. A nice example is a stock that I invested in last year...CMXI (Cytomedix). They make specialized medical equipment and are about to see sales ramp hard as they sign a deal with a top 20 global pharma. EKO should have taken this approach with their masks. Perhaps, they will eventually do this with their filters. Nevertheless, if ECM had a bigger, organized sales force ...more  
Comment by MoneyK on Apr 09, 2012 1:34pm
Si c'est faux que tu ne peux pas comprendre, alors tant pis pour toi! lol   True bfw, they need to do something and that would be a great avenue.   MoneyK
Comment by bambam98ca on Apr 09, 2012 4:03pm
It's not because they can sell scanners in Algeria and sell filters in Montreal that they can ramp up sales! Both are complete opposites! All these guys are ramping up are loses! They had their chances with 3m,Kimberly,Schein, and they messed it up thinking the world would get on their knees to beg to do business with them!
Comment by rickydee on Apr 09, 2012 5:30pm
This post has been removed in accordance with Community Policy
Comment by bambam98ca on Apr 09, 2012 5:49pm
Ricky! U no phoque all!
Comment by rickydee on Apr 09, 2012 5:57pm
This post has been removed in accordance with Community Policy
Comment by bambam98ca on Apr 09, 2012 7:11pm
I know enough to get the phoque out in the 40's I know your losing $1 mill I know they blew through $140 mill
Comment by rickydee on Apr 09, 2012 7:23pm
This post has been removed in accordance with Community Policy
Comment by bambam98ca on Apr 09, 2012 7:25pm
Now your both broke now your both broke Now your both broke
Comment by rickydee on Apr 10, 2012 6:56am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities